Skip to content

Clinical trials

Phase 3 Esophageal Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Phase: Phase 3 Clear all

114 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20012
20024
20031
20041
20052
20062
20073
20086
20093
20102
20111
20123
20134
20144
20159
20167
20177
20186
20194
20206
20214
20226
20231
20246
20254
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Unknown status33
Recruiting20
Not yet recruiting8
Terminated5
Active, not recruiting4
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese Academy of Medical Sciences7
Sun Yat-sen University5
Fudan University4
Fujian Medical University Union Hospital4
Merck Sharp & Dohme LLC4
Alliance for Clinical Trials in Oncology3
Cancer Institute and Hospital, Chinese Academy of Medical Sciences3
Henan Cancer Hospital3
Shanghai Chest Hospital3
The First Affiliated Hospital of Henan University of Science and Technology3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms114
Esophageal Squamous Cell Carcinoma16
Stomach Neoplasms16
Bile Duct Neoplasms4
Carcinoma, Squamous Cell4
Lung Neoplasms4
Neoplasms4
Pancreatic Neoplasms4
Breast Neoplasms3
Carcinoma, Non-Small-Cell Lung3

Trials

Showing 26 to 50 of 114. Each trial links to its page on Pharma Observatory.

14 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.